Merus
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Merus and other ETFs, options, and stocks.About MRUS
Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors.
CEOSven Ante Lundberg
CEOSven Ante Lundberg
Employees260
Employees260
HeadquartersUtrecht, Utrecht
HeadquartersUtrecht, Utrecht
Founded2003
Founded2003
Employees260
Employees260
MRUS Key Statistics
Market cap2.89B
Market cap2.89B
Price-Earnings ratio-12.62
Price-Earnings ratio-12.62
Dividend yield—
Dividend yield—
Average volume823.75K
Average volume823.75K
High today$45.90
High today$45.90
Low today$40.72
Low today$40.72
Open price$44.29
Open price$44.29
Volume1.72M
Volume1.72M
52 Week high$61.61
52 Week high$61.61
52 Week low$33.19
52 Week low$33.19
MRUS News
TipRanks 3d
Merus’s Strategic Positioning and Growth Potential Justifies Buy RatingCharles Zhu, an analyst from LifeSci Capital, maintained the Buy rating on Merus (MRUS – Research Report). The associated price target remains the same with $11...
Analyst ratings
100%
of 17 ratingsBuy
100%
Hold
0%
Sell
0%